Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer-an IMMUNOTARGET case series. | Transl Lung Cancer Res | 2022 | 36636412 | PubTator, text mining | PubMed |
| Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. | World J Gastroenterol | 2022 | 36632312 | PubTator, text mining | PubMed |
| Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation. | Cancers (Basel) | 2022 | 36612287 | PubTator, text mining | PubMed |
| Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management. | Cancers (Basel) | 2022 | 36612173 | PubTator, text mining | PubMed |
| Functional Role of AGAP2/PIKE-A in Fcγ Receptor-Mediated Phagocytosis. | Cells | 2022 | 36611866 | PubTator, text mining | PubMed |
| Clinically relevant fusion oncogenes: detection and practical implications. | Ther Adv Med Oncol | 2022 | 36601633 | PubTator, text mining | PubMed |
Molecular, morphological and functional properties of tunnelling nanotubes between normal and cancer urothelial cells: New insights from the in vitro model mimicking the situation after surgical removal of the urothelial tumor. | Front Cell Dev Biol | 2022 | 36601539 | PubTator, text mining | PubMed |
| MiR-150 blunts cardiac dysfunction in mice with cardiomyocyte loss of β1-adrenergic receptor/β-arrestin signaling and controls a unique transcriptome. | Cell Death Discov | 2022 | 36585403 | PubTator, text mining | PubMed |
| Targeted therapy of RET fusion-positive non-small cell lung cancer. | Front Oncol | 2022 | 36582799 | PubTator, text mining | PubMed |
| Function and return to sports after proximal humeral replacement in patients with primary bone sarcoma. | J Orthop Traumatol | 2022 | 36571630 | PubTator, text mining | PubMed |
| Case report: Recurrent lung infections following treatment with pralsetinib for an elderly patient with RET-fusion positive NSCLC. | Front Oncol | 2022 | 36568233 | PubTator, text mining | PubMed |
| Precious Gene: The Application of RET-Altered Inhibitors. | Molecules | 2022 | 36557971 | PubTator, text mining | PubMed |
| Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases. | Int J Mol Sci | 2022 | 36555098 | PubTator, text mining | PubMed |
| Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations. | Nat Commun | 2022 | 36550158 | PubTator, text mining | PubMed |
| Advances in the study of axon-associated vesicles. | Front Mol Neurosci | 2022 | 36545123 | PubTator, text mining | PubMed |
| Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. | Ther Adv Med Oncol | 2022 | 36544541 | PubTator, text mining | PubMed |
| Structural basis for Parkinson's disease-linked LRRK2's binding to microtubules. | Nat Struct Mol Biol | 2022 | 36510024 | PubTator, text mining | PubMed |
| Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. | Mol Biomed | 2022 | 36508072 | PubTator, text mining | PubMed |
| Role of AMPK in autophagy. | Front Physiol | 2022 | 36505072 | PubTator, text mining | PubMed |
| Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance. | Int J Mol Sci | 2022 | 36499382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=21